Working Through Safety Concerns and the Future of Computer Assisted Propofol Sedation
While there have been some concerns raised about computer assisted propofol sedation studies have shown it to be a safe and effective method when conducted by properly trained healthcare professionals. Work is also being done to ensure better results in the future.
Measuring Patient Experience With Computer Assisted Propofol Sedation
According to research done on computer assisted propofol sedation patients see a faster recovery time by approximately 6 minutes on average. This can help not only the patients to leave the recovery area faster, but can also put less of a burden on the staff and location of their endoscopic procedure.
What is Computer-Assisted Propofol Sedation?
When undergoing endoscopic procedures it is important that patients receive the proper pain medication. A recent study looked at whether a computer can assist in the process to keep the patients comfortable allow them to continue on their day after the procedure.
Using High Definition for Chromoendoscopy to Detect Dysplasia in Patients with Ulcerative Colitis
Gastroenterologist Venkat Subramanian, MD, discusses the use of high-definition screens and dyes during endoscopy to detect cancerous and noncancerous lesions in patients with ulcerative colitis
Hepatitis C Drugs: Insurers' Reasons for Coverage Denials
Treating hepatitis C with new antivirals saves lives and-in the long run-money spent on patient care. But some patients and their physicians are learning there are barriers to getting prescriptions approved by patients' insurance carriers.
Race Not a Factor in Hepatitis C Survival
African Americans are more likely to be infected with the hepatitis C virus than Caucasians. But that does not mean they are more likely to die from the disease, researchers reported at the 2015 Digestive Disease Week conference in Washington, DC.
Hep C: Baby Boomer Test Results
A relatively higher rate of hepatitis C infection in US adults considered to be part of the baby boom generation is starting to decline, researchers report. The statistical drop started the year after a CDC push for all US adults to get tested.
Hep C Drugs: Not Always Covered
A recent study found that while most insurers are paying for the new hepatitis C antivirals, disparities exist. More than 20% of patients at the hospital studied who had private insurance were refused their prescriptions for sofosbuvir with simeprevir, the researchers found.
Promising Drug for C. difficile Infection Prevention
A drug that shows promise in protecting the human gut microbiome from antiobiotic assaults that can lead to C. difficile infection is about to enter Phase 2 trials. So far, it has worked well in lab pigs, researchers said at Digestive Disease Week 2015.
FMT: Colonoscopy Outperforms Endoscopy
Reporting at the 2015 Digestive Disease Week conference in Washington, DC, a research team from Scott and White Memorial Hospital in Temple, Texas, found that colonoscopy has the edge over upper endoscopy in fecal microbiota transplant.
Fecal Transplant Overprescribed?
Transplanting a healthy person's fecal microbiota into the digestive tract of a patient believed to have a recurrent C. difficile infection has gone from obscurity to an accepted treatggggment. But a new study finds it was wrongly proposed for more than 25% of patients referred for treatment.
Proximal and Distal Colon Have Different Vitamin D Responses
The proximal and distal colon act like two different organs when it comes to biological function and the microbiota that live there. The difference is seen even at the gene transcriptional level and response to vitamin D, a team of researchers from the University of Chicago reported.
Stool Banks and Their Role in Fecal Microbiota Transplantation
With the incidence and severity of Clostridium difficile infection increasing every year, the growing acceptance of fecal transplant as a viable treatment may mean stool banks will become as common as sperm and blood banks.
Fecal Microbiota Transplantation Now and in the Future
For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.
Colonoscopy Prep Made Palatable
Patients recommended for screening colonoscopy often resist because the bowel cleansing regimen is unpleasant. In an abstract presented at the 2015 Digestive Disease Week conference in Washington, DC, Campbell Levy, MD, of Dartmouth-Hitchcock Medical Center in Lebanon, NH, and colleagues at other institutions reported on a novel edible product that achieves the desired results.
New Prep Method Looks to Make Colonoscopy Easier to Swallow
For anyone who has undergone a colonoscopy the worst part of the procedure is usually the preparation. Between the fluids that need to be ingested and the necessary fasting, it can be a long process before ever seeing the doctor. A recent pilot study looked at ways to change that.
International Fecal Bank Feasible
Fecal microbiota transplantation (FMT) is a proven therapy for recurrent C. difficile infection. A team of researchers from OpenBiome outlined plans for a depository for frozen stool from screened donors. The goal is to have a consistent and safe product for use by clinicians who treat patients with this ailment.